IL117113A0 - Mutant proteins - Google Patents

Mutant proteins

Info

Publication number
IL117113A0
IL117113A0 IL11711396A IL11711396A IL117113A0 IL 117113 A0 IL117113 A0 IL 117113A0 IL 11711396 A IL11711396 A IL 11711396A IL 11711396 A IL11711396 A IL 11711396A IL 117113 A0 IL117113 A0 IL 117113A0
Authority
IL
Israel
Prior art keywords
mutant proteins
mutant
proteins
Prior art date
Application number
IL11711396A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL117113A0 publication Critical patent/IL117113A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11711396A 1995-02-13 1996-02-12 Mutant proteins IL117113A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds

Publications (1)

Publication Number Publication Date
IL117113A0 true IL117113A0 (en) 1996-06-18

Family

ID=26306494

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11711396A IL117113A0 (en) 1995-02-13 1996-02-12 Mutant proteins

Country Status (15)

Country Link
EP (1) EP0811060A1 (en)
JP (1) JPH10509327A (en)
KR (1) KR19980702160A (en)
CN (1) CN1173897A (en)
AU (1) AU4665196A (en)
BR (1) BR9606951A (en)
CA (1) CA2210538A1 (en)
CZ (1) CZ255397A3 (en)
FI (1) FI972763A (en)
HU (1) HUP9801681A3 (en)
IL (1) IL117113A0 (en)
NO (1) NO973679L (en)
PL (1) PL321239A1 (en)
SK (1) SK109997A3 (en)
WO (1) WO1996025492A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296105A1 (en) * 1997-06-30 1999-01-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel inhibitor of cellular proliferation
US7968523B2 (en) * 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US6867237B1 (en) * 2001-07-23 2005-03-15 Senesco Technologies, Inc. DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
US7381708B2 (en) 2001-07-23 2008-06-03 Sensco Technologies, Inc. Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
JP2006520611A (en) 2003-03-05 2006-09-14 セネスコ テクノロジーズ，インコーポレイティド Use of antisense oligonucleotides or siRNA to suppress the expression of eIF-5A1
WO2005007853A2 (en) * 2003-06-06 2005-01-27 Senesco Technologies, Inc. Inhibition of apoptosis-specific elf-5a (“eif-5a1”) with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics
CA2717637A1 (en) 2008-03-07 2009-09-17 Senesco Technologies, Inc. Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide
US8445638B2 (en) 2008-09-03 2013-05-21 Senesco Technologies, Inc. Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Also Published As

Publication number Publication date
AU4665196A (en) 1996-09-04
EP0811060A1 (en) 1997-12-10
HUP9801681A3 (en) 2000-10-30
HUP9801681A2 (en) 1998-10-28
SK109997A3 (en) 1998-04-08
WO1996025492A1 (en) 1996-08-22
MX9705757A (en) 1998-07-31
BR9606951A (en) 1997-10-28
FI972763A0 (en) 1997-06-26
NO973679L (en) 1997-10-13
KR19980702160A (en) 1998-07-15
PL321239A1 (en) 1997-11-24
FI972763A (en) 1997-10-10
JPH10509327A (en) 1998-09-14
CA2210538A1 (en) 1996-08-22
CN1173897A (en) 1998-02-18
CZ255397A3 (en) 1998-02-18
NO973679D0 (en) 1997-08-11

Similar Documents

Publication Publication Date Title
PL324453A1 (en) Sold greasea
GB2306485B (en) Enzyme mutant
GB9510830D0 (en) Proteins
IL117113A0 (en) Mutant proteins
AU7520396A (en) Abl-interactor protein
AU5284296A (en) Immune-evading proteins
GB9519865D0 (en) Protein
AU6153396A (en) E6ap-binding proteins
GB9622436D0 (en) Protein
AP9600802A0 (en) Libricant
GB9722556D0 (en) Methods
ZA961162B (en) Mutant proteins.
GB9319747D0 (en) Mutant proteins
GB9524341D0 (en) Proteins
GB9502138D0 (en) Proteins
GB9509102D0 (en) Modified proteins
GB9522660D0 (en) Protein
GB9516227D0 (en) Re-textured protein
GB9511729D0 (en) Protein
GB9501486D0 (en) Protein
AU1105P (en) DALESE Metrosideros excelsus
GB9501940D0 (en) Radiolabelled proteins
GB9509984D0 (en) Radiolabelled proteins
GB9518645D0 (en) Radiolabelled proteins
GB9514835D0 (en) Polypeptide